US PHARMACIST

Scope & Guideline

Elevating Pharmacy Education for Practitioners and Students

Introduction

Delve into the academic richness of US PHARMACIST with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN0148-4818
PublisherJOBSON PUBLISHING LLC
Support Open AccessNo
CountryUnited States
TypeTrade Journal
Converge1979, from 1990 to 1996, from 2007 to 2024
AbbreviationUS PHARM / US Pharm.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address100 AVE OF THE AMERICAS, NEW YORK, NY 10013-1678

Aims and Scopes

The journal 'US Pharmacist' focuses on advancing the knowledge and practice of pharmacy through a broad range of topics that address current issues, therapeutic advancements, clinical guidelines, and the pharmacist's role in patient care.
  1. Pharmacotherapy and Treatment Guidelines:
    The journal consistently covers pharmacotherapy options and treatment guidelines across various diseases, including chronic conditions, infectious diseases, and mental health disorders, emphasizing evidence-based practices.
  2. Role of Pharmacists in Healthcare:
    A significant focus is placed on the evolving role of pharmacists in patient care, including their involvement in immunizations, managing chronic diseases, and addressing health disparities, showcasing the importance of pharmacists in the healthcare system.
  3. Emerging Therapies and Drug Approvals:
    The journal highlights recent advancements in drug approvals and emerging therapies, particularly for complex conditions such as cancer, diabetes, and infectious diseases, providing pharmacists with the latest information to enhance patient care.
  4. Public Health and Preventive Care:
    Topics related to public health initiatives, preventive care strategies, and health education are prominently featured, reflecting the journal's commitment to improving community health outcomes.
  5. Mental Health and Substance Use Disorders:
    The journal addresses the intersection of mental health and substance use, discussing pharmacological and non-pharmacological interventions, thereby supporting pharmacists in managing these complex issues.
The 'US Pharmacist' journal has shown a dynamic evolution in its focus areas, with several emerging and trending themes reflecting contemporary challenges and advancements in pharmacy practice.
  1. Telehealth and Digital Health Solutions:
    There is a growing emphasis on telehealth and digital health solutions, driven by the COVID-19 pandemic's impact on healthcare delivery, showcasing the importance of pharmacists in virtual care settings.
  2. Pharmacogenomics and Personalized Medicine:
    The trend towards personalized medicine and pharmacogenomics is gaining traction, with increasing discussions on how genetic factors influence drug therapy and patient outcomes, indicating a shift towards precision medicine.
  3. Mental Health Interventions:
    Recent publications highlight a surge in topics related to mental health interventions, reflecting a broader recognition of mental health's importance in overall patient care and the pharmacist's role in managing these conditions.
  4. Health Disparities and Equity:
    Emerging discussions around health disparities and equity emphasize the role of pharmacists in addressing social determinants of health, aligning with national initiatives aimed at reducing healthcare inequities.
  5. Innovations in Chronic Disease Management:
    There is an increasing focus on innovative approaches to managing chronic diseases, particularly through the use of new technologies and therapies, which are crucial for improving patient outcomes.

Declining or Waning

While 'US Pharmacist' has a robust array of topics, some themes appear to be declining in prominence based on recent publications. This may reflect shifting priorities within the field of pharmacy and healthcare.
  1. Traditional Infectious Disease Management:
    There has been a noticeable decline in articles specifically focused on traditional infectious disease management, possibly due to the saturation of content in previous years and a shift towards more innovative and complex therapeutic discussions.
  2. General Nutritional Supplements:
    The frequency of articles discussing general nutritional supplements has decreased, suggesting a possible waning interest as pharmacists increasingly focus on evidence-based pharmacotherapy over supplementation.
  3. Basic Patient Education Topics:
    Basic patient education topics, while still important, are less frequently covered as the journal shifts to more advanced and specialized content that addresses complex pharmaceutical care issues.

Similar Journals

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Connecting professionals to the pulse of health-system pharmacy.
Publisher: OXFORD UNIV PRESS INCISSN: 1079-2082Frequency: 24 issues/year

American Journal of Health-System Pharmacy, published by Oxford University Press Inc., stands as a vital resource in the domains of pharmacy and health policy. With an ISSN of 1079-2082 and E-ISSN 1535-2900, this esteemed journal provides a platform for disseminating high-quality research and insights that influence the practice of pharmacy and health management. The journal boasts a Q1 ranking in Pharmacy and ranks within the top quartiles in Health Policy and Medicine, reflecting its substantial impact on the field. With a comprehensive focus extending from 1995 to 2024, it caters to a diverse audience, including health professionals, researchers, and students interested in the ever-evolving dynamics of health-system pharmacy. Although it does not offer Open Access, the journal ensures that subscribers gain access to cutting-edge research essential for advancing health implications in pharmacy practice. By prioritizing innovative studies and reviews, the American Journal of Health-System Pharmacy plays a crucial role in shaping effective pharmaceutical care strategies and policies.

JOURNAL OF PHARMACY PRACTICE AND RESEARCH

Empowering pharmacists with evidence-based findings.
Publisher: WILEYISSN: 1445-937XFrequency: 6 issues/year

JOURNAL OF PHARMACY PRACTICE AND RESEARCH is a pivotal platform dedicated to advancing knowledge and practice in the fields of pharmacy and pharmacology. Published by WILEY, this journal boasts a commendable impact factor, reflecting its contribution to the scientific community. With an ISSN of 1445-937X and E-ISSN 2055-2335, it emphasizes high-quality, peer-reviewed research essential for pharmacists, healthcare professionals, and researchers. Operating without an open-access model, it currently holds a Q3 ranking in Pharmacology and a Q2 ranking in Pharmacy according to the 2023 category quartiles, positioning it as a key resource for evidence-based practices and recent innovations in the pharmaceutical sciences. The journal spans from 2002 to 2024 and is recognized for enhancing the dialogue between academia and clinical practice. It provides a vital portal for exploring contemporary research trends and addressing pressing challenges in pharmacy practice, making it an indispensable resource for advancing professional development and improving patient care.

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Empowering practitioners with innovative medication insights.
Publisher: WILEY-HINDAWIISSN: 0269-4727Frequency: 1 issue/year

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, an esteemed publication in the field of pharmacology, is published by Wiley-Hindawi and has been at the forefront of clinical research since its inception in 1976. Operating primarily from the United Kingdom, this journal features a diverse array of articles that encompass both fundamental and practical aspects of clinical pharmacy, thereby supporting the advancement of therapeutic practices. With an ISSN of 0269-4727 and an E-ISSN of 1365-2710, it is indexed in key databases and holds respectable ranks within its categories; achieving Q3 in Pharmacology and Q2 in Medical Pharmacology in the latest quartile rankings. Its Scopus ranking reflects both its quality and relevance, being positioned in the 55th percentile for medical pharmacology and the 45th for pharmacology, toxicology, and pharmaceutics. Although it does not currently operate under an Open Access model, the journal's extensive readership and rigorous peer-review process ensure that the latest research reaches practitioners and academics alike. With a commitment to bridging the gap between pharmacological science and clinical practice, the JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS remains a critical resource for professionals striving to enhance patient outcomes through informed medication management.

Exploratory Research in Clinical and Social Pharmacy

Exploring the intersection of clinical and social pharmacy.
Publisher: ELSEVIERISSN: Frequency: 4 issues/year

Exploratory Research in Clinical and Social Pharmacy is a leading peer-reviewed journal published by Elsevier, dedicated to advancing knowledge and research in the field of pharmacy and its intersection with clinical and social dimensions. Since its inception in 2021, the journal has carved out an essential niche in the academic community, as reflected by its strong impact factor and reputable category rankings, including Q3 in Health, Toxicology and Mutagenesis, Q3 in Pharmacology (Medical), and Q1 in Pharmacy as of 2023. The journal aims to disseminate innovative research findings, case studies, and reviews that address contemporary challenges and solutions within the pharmacy discipline, making it a vital resource for researchers, healthcare professionals, and students alike. With its emphasis on open access, Exploratory Research in Clinical and Social Pharmacy is committed to promoting inclusive and widespread expertise within the field, facilitating collaboration and knowledge transfer across global audiences. For its readers, this journal promises to be an invaluable tool for staying updated with the latest trends and advancements in pharmacy practice and research.

Journal of Pharmaceutical Policy and Practice

Leading the way in pharmaceutical policy and practice innovation.
Publisher: TAYLOR & FRANCIS LTDISSN: Frequency: 1 issue/year

Journal of Pharmaceutical Policy and Practice, published by Taylor & Francis Ltd, is a premier open access journal dedicated to advancing the field of pharmaceutical policy and practice. Launched in 2013, this esteemed journal has rapidly become a vital resource for researchers, practitioners, and policymakers alike, offering a critical examination of health policies and their implementation in pharmaceutical contexts. With an impressive impact factor reflecting its significance, it ranks in the Q2 category for Health Policy and Q1 in both Pharmacology, Toxicology and Pharmaceutics and Pharmacy, showcasing its high-quality contributions to the field. Accessible to a global audience since 2014, the journal disseminates innovative research findings that inform best practices, foster policy development, and enhance patient outcomes in the pharmaceutical landscape. Positioned in the UK and with strong Scopus rankings, specifically ranked #3 in Health Professions (Pharmacy), the journal serves as an essential platform for those striving to navigate the ever-evolving intersection of healthcare and pharmaceutical sciences.

Integrated Pharmacy Research and Practice

Empowering healthcare with integrated pharmaceutical insights.
Publisher: DOVE MEDICAL PRESS LTDISSN: 2230-5254Frequency: 1 issue/year

Integrated Pharmacy Research and Practice is a peer-reviewed, open-access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the field of pharmacy through innovative research and practice. With its ISSN 2230-5254, the journal has been providing a vital platform for disseminating new findings and best practices since its inception in 2012. Targeting researchers, practitioners, and students alike, it encompasses a broad scope that includes clinical pharmacy, drug regulation, and the socio-economic impact of pharmacy practices. Positioned in New Zealand's vibrant academic landscape, the journal aims to foster collaboration and knowledge sharing among professionals while upholding rigorous standards of scientific integrity. By offering unrestricted access to its content, Integrated Pharmacy Research and Practice plays a crucial role in shaping the future of pharmaceutical sciences and enhancing patient care globally.

Turkish Journal of Pharmaceutical Sciences

Unlocking the Potential of Pharmaceutical Research
Publisher: GALENOS PUBL HOUSEISSN: 1304-530XFrequency: 6 issues/year

The Turkish Journal of Pharmaceutical Sciences, an esteemed publication by GALENOS PUBL HOUSE, has been a prominent platform for research and innovation in the fields of Pharmaceutical Sciences and Molecular Medicine since its inception as an Open Access journal in 2004. Based in Turkey, this journal serves as a vital resource for researchers, professionals, and students keen on exploring the latest advancements in drug development, pharmacology, and therapeutic innovations. With an ISSN of 1304-530X and an E-ISSN of 2148-6247, the journal is indexed in leading databases and has demonstrated strong rankings in the Scopus index, notably securing the second quartile in Pharmaceutical Sciences. Furthermore, it fosters academic collaboration and knowledge dissemination by making its content freely accessible. The journal aims to inspire groundbreaking research, providing an important academic forum for the dissemination of valuable insights that impact the pharmaceutical sector and contribute to global health.

Journal of Young Pharmacists

Transforming Ideas into Impactful Research
Publisher: INPHARM ASSOC, PHCOG NETISSN: 0975-1483Frequency: 4 issues/year

Journal of Young Pharmacists is a distinguished peer-reviewed journal published by INPHARM ASSOCIATION in collaboration with PHCOG NET. With an ISSN of 0975-1483 and an E-ISSN of 0975-1505, this journal serves as a vital platform for disseminating pioneering research in the field of pharmacology and toxicology. Although coverage in Scopus was discontinued in 2018, the journal continues to be important in educating future pharmacists and advancing the discipline, evident from its ranking in the 29th percentile among general pharmacology journals. The Journal of Young Pharmacists seeks to bridge the gap between theoretical knowledge and practical application, encouraging young researchers, professionals, and students to contribute their insights and findings. The journal emphasizes innovative approaches and contemporary issues relevant to the pharmaceutical sciences, making it an invaluable resource for anyone involved in this dynamic field.

MEDICAL LETTER ON DRUGS AND THERAPEUTICS

Elevating Pharmacological Knowledge for Better Care
Publisher: MED LETTER INCISSN: 0025-732XFrequency: 26 issues/year

MEDICAL LETTER ON DRUGS AND THERAPEUTICS is a pivotal resource for professionals in the fields of medicine and pharmacology, published by MED LETTER INC. Since its inception in 1965, this journal has been committed to elucidating the complexities of drug therapy and clinical therapeutics, offering readers evidence-based insights and critical evaluations of the latest medications and treatment protocols. With a quarterly ranking reflecting its stature—Q4 in Medicine (Miscellaneous) and Q3 in both Pharmacology and Pharmacology (Medical)—the journal maintains a specific niche ensuring readers are equipped with updated information that continues to influence healthcare practices. Although it does not operate under an open access model, the journal is accessible to institutions and professionals eager to stay at the forefront of medicinal advancements. The importance of this journal lies in its dedication to enhancing pharmacological knowledge, thus catering to the needs of researchers, healthcare providers, and students alike, making it an essential addition to the literature in therapeutic drug interventions.

Pharmacy Practice-Granada

Empowering pharmacy practice through innovative research.
Publisher: CENTRO INVESTIGACIONES & PUBLICACIONES FARMACEUTICASISSN: 1885-642XFrequency: 4 issues/year

Pharmacy Practice-Granada is an esteemed academic journal dedicated to advancing the field of pharmacy and pharmaceutical sciences. Published by CENTRO INVESTIGACIONES & PUBLICACIONES FARMACEUTICAS, this journal has been a pioneer in Open Access publishing since 2006, allowing researchers worldwide to disseminate their findings without barriers. Operating out of Spain, it provides a platform for innovative research and critical discourse in pharmaceutical practice and education. As of 2023, the journal is ranked in the Q2 category for Pharmaceutical Science and holds a prestigious Q1 ranking in Pharmacy, reflecting its impact and contribution within the academic community. With a strong Scopus ranking, positioned as #6 out of 45 in Health Professions – Pharmacy and a percentile of 87%, the journal serves as a vital resource for practitioners, researchers, and students alike who are committed to enhancing health outcomes through pharmacy. With a commitment to high-quality research, Pharmacy Practice-Granada aims to support knowledge exchange and foster collaborative efforts, ultimately shaping the future of pharmaceutical care.